Brief: Cabaletta Bio - Cash, Cash Equivalents And Short-Term Investments Expected To Support Operations Into Q4 2025
09/11/2023 12:34
Nov 9 (Reuters) - Cabaletta Bio Inc CABA.O :
* CABALETTA BIO REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
* CABALETTA BIO INC - CASH, CASH EQUIVALENTS AND SHORT-TERM
INVESTMENTS EXPECTED TO SUPPORT OPERATIONS INTO Q4 OF 2025
Source text for Eikon: ID:nGNX6NZsS3
Further company coverage: CABA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cabaletta Bio
See all newsBrief: Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Cabaletta Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cabaletta Bio Q2 net loss widens as R&D costs rise
Cabaletta Bio, Inc. expected to post a loss of 37 cents a share - Earnings Preview
Cabaletta Bio Inc expected to post a loss of 37 cents a share - Earnings Preview